Author

Ashraf R. Aziz

Observed name: Ashraf R Aziz

Institutions: Kaiser Permanente, Kaiser Permanente Anaheim Medical Center

Observed institutions: Kaiser Permanente, Brookdale University Hospital and Medical Center, Kaiser Permanente Anaheim Medical Center

OpenAlex ID: A5013477779

Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181

2024 · Nina Wagner-Johnston, Opeyemi Jegede, et al. · Blood · 9

Systemic lupus erythematosus presenting with pancytopenia due to bone marrow myelofibrosis in a 22-year-old male.

2004 · Ashraf R Aziz, Yahya Mohammadian, et al. · PubMed · 7

Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study

2024 · Helen W. Wong, Vivian H. Nguyen, et al. · BioDrugs · 2

Evaluation of outcomes between rituximab-abbs and reference product rituximab in adult patients with newly diagnosed diffuse large B-cell lymphoma in a non-inferiority study.

2023 · Vivian Nguyen, Helen Wong, et al. · Journal of Clinical Oncology

Good Response to Decitabine in an Elderly Patient with MDS (Refractory Anemia with Excess Blasts RAEB-2) after Failure of Azacitidine.

2007 · Ashraf R. Aziz · Blood

Works count: 5

Citation count: 18

H-index: 2

I10-index: